Indexé dans
- Base de données des revues académiques
- Ouvrir la porte J
- Genamics JournalSeek
- Clés académiques
- JournalTOCs
- Infrastructure nationale des connaissances en Chine (CNKI)
- CiteFactor
- Scimago
- Répertoire des périodiques d'Ulrich
- Bibliothèque des revues électroniques
- RechercheRef
- Université Hamdard
- EBSCO AZ
- OCLC - WorldCat
- Catalogue en ligne SWB
- Bibliothèque virtuelle de biologie (vifabio)
- Publions
- MIAR
- Commission des bourses universitaires
- Fondation genevoise pour la formation et la recherche médicales
- Pub européen
- Google Scholar
Liens utiles
Partager cette page
Dépliant de journal
Revues en libre accès
- Agriculture et aquaculture
- Alimentation et nutrition
- Biochimie
- Bioinformatique et biologie des systèmes
- Business & Management
- Chimie
- Génétique et biologie moléculaire
- Immunologie & Microbiologie
- Ingénierie
- La science des matériaux
- Neurosciences & Psychologie
- Science générale
- Sciences cliniques
- Sciences environnementales
- Sciences médicales
- Sciences pharmaceutiques
- Sciences vétérinaires
- Soins infirmiers et soins de santé
Abstrait
Medicine Interchangeabilty in Brazil, is it Safe? A Systematic Review for the Last 15 Years about Oral Drugs
Gabriel Silva Lima*, Gustavo Reis Sampaio, Denis de Melo Soares
Objectives: The goal of this study was to review studies about bioequivalence test (BE) for oral drugs interchangeability in Brazil.
Methods: We searched two databases with a strict inclusion process: Conducted in Brazil; humans volunteers; cover the period from 2004 to 2019; be a comparative study between oral formulations; at least one Brazilian formulation under test and published in periodic; Two reviewers independently extracted the data.
Results: 4628 articles screened; 68 articles were included. 67 applying clinical assays and 1 article Chow and Liu methodology. Across studies that evaluated BE by clinical assays 66 demonstrated BE comparing generic or similar to their reference medicine.
Conclusion: These data can be used to inform interventions to change the public’s beliefs about a safe use of generic or similar drugs; and avoiding substitution between copies.